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Abstract
As part of a virus discovery investigation using a metagenomic approach, a highly divergent novel Human papillomavirus
type was identified in pooled convenience nasal/oropharyngeal swab samples collected from patients with febrile
respiratory illness. Phylogenetic analysis of the whole genome and the L1 gene reveals that the new HPV identified in this
study clusters with previously described gamma papillomaviruses, sharing only 61.1% (whole genome) and 63.1% (L1)
sequence identity with its closest relative in the Papillomavirus episteme (PAVE) database. This new virus was named
HPV_SD2 pending official classification. The complete genome of HPV-SD2 is 7,299 bp long (36.3% G/C) and contains 7
open reading frames (L2, L1, E6, E7, E1, E2 and E4) and a non-coding long control region (LCR) between L1 and E6. The
metagenomic procedures, coupled with the bioinformatic methods described herein are well suited to detect small circular
genomes such as those of human papillomaviruses.
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Introduction
Papillomaviruses (PV) are small, circular, double-stranded DNA
viruses belonging to Papillomaviridae, a large family with over 180
viruses phylogenetically classified in groups, genera, and species
[1,2]. The PVs infecting human, the human PV (HPVs), encompass
highly pathogenic viruses causing a wide range of diseases including
cervical, vulval,penile,oropharyngealandanalwartsandcancers[3–
6]. Over 150 genomes of HPVs have been fully sequenced,
characterized and catalogued by the Papillomavirus Episteme
(PAVE) database. It is likely that more unknown HPV types are yet
to be discovered, and may be circulating between humans, animals
and their respectiveenvironments. It isnecessary todetermine the full
picture of the genetic diversity, the host-range and the clinical
relevanceof thevastmajorityofHPVs,whichthus farremainunclear.
One obstacle to discovering novel HPVs viruses has been the lack of
suitable laboratory techniques and computationalmethods to survey
environments and biological samples.
While various laboratory techniques for the detection of known
HPVs are readily available, they are unpredictable for find highly
divergent viruses in biological and ecological environments.
Although generally viewed as the gold standard of novel virus
discovery, tissue culture techniques are inefficient to propagate
HPVs [2]. Therefore, the detection of HPVs primarily relies on
molecular techniques such as PCR using consensus primers [7,8],
and the sequencing of a subset of the genome. The subsequent
genotyping of the partial genome of HPV is generally carried out
by pair-wise comparison of the sequences with the corresponding
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genes of known viruses. This approach can lead to analytical
difficulties when non-overlapping genomic regions of different
viruses are compared. Moreover, PCR using consensus primers is
inadequate for highly distant and novel HPVs that can only
detected by metagenomics [7]. In order to assign taxonomical
classification, the PV Working Group of the International
Committee on Taxonomy of Viruses recommends that researchers
analyze at least the complete gene encoding the major capsid
protein, L1 [1].
With the advent of metagenomics using high-throughput
sequencing technology [9–12], it is possible to generate the full
genome of phylogenetically HPVs at relatively low cost and
unprecedented speed, regardless of genetic divergence from known
viruses. Metagenomics is a culture-independent technique and
does not depend on a priori knowledge of the genetic information of
the organism to be detected [9–12].
As part of a virus discovery consortium between San Diego
State University, Global Viral Forecasting and the Naval Health
Research Center, we applied the metagenomic approach to
pooled convenience samples obtained from patients with re-
spiratory illness, and identified a novel gamma papillomavirus that
is highly divergent compared to previously known HPVs.
Results and Discussion
Overall Taxonomic Classification of Metagenomic Reads
Sequencing reads generated by high-throughput sequencing
were assembled with a threshold of 95% identity and at least 45 nt
overlap and subjected to taxonomical classification using BLASTn
against the Genbank database employing a stringent cut-off E-
value of #1025.
The proportion of sequence reads with significant hits to viruses,
bacteria andeukaryotes are summarized inFigure 1 (details provided
as Document S1). Overall, of the 2,027,673 reads generated in this
study, 120,801 (6%) were classified as bacterial, 30,259 (1.5%)
mapped to known viruses and 6,373 (0.3%) were classified as
originating from eukaryotic cells. Details of viruses identified in this
study by BLASTn analysis are presented in Table 1, showing that
both DNA and RNA viruses were identified in nasopharyngeal
samples. These included human enterovirus, Torque teno virus,
human rhinovirus, SEN virus and HPV. The HPV identified by
BLAST consists of 5 contigs with significant hit to HPV_49. We
combined these 5 contigs into a scaffold of length 6,356 bp, and will
further refer to this scaffold as HPV_SD1 in the further analyses
(below).The remaining 1,870,240 reads (92%) couldnot be classified
as belonging to previously defined taxa. Such sequences are referred
to as ‘unknowns’ throughout this paper.
Deciphering the Unknowns
Further analyses were performed to determine the origin of the
unknown sequences. First, we developed a script (circular_fro-
m_ACE.pl, Document S2) to determine whether the contigs were
circular. Second, any circular genomes identified were subjected to
PlasMapper analysis [13] to determine if they were bacteria or
plasmids. Third, all unknown sequences were tested with
tBLASTx using a very relaxed E value cutoff. Finally, sequences
with hits to known viruses with relaxed E value were confirmed by
phylogenetic analysis.
The circular_from_ACE.pl script used the ACE files generated
by the De Novo Assembler and determined whether exact copies of
overhanging sequences at both 59 and 39 ends of the assembly
were found within the contigs (Figure 2.A). Figure 2B depicts the
striking similarity between overhanging fragments at the 59 and
the 39 ends, and sequences in their respective opposite ends of the
contig. Of 2,075 contigs analyzed, 193 (9.3%) met the criteria
suggestive of having a circular DNA structure.
Many viral genomes including HPVs and all bacterial plasmids
are characteristically circular. However, plasmids have character-
istic features, including the origin of replication, which can
distinguish them from viruses. The feature is seldom found among
viruses, with rare exceptions such as Epstein-Barr virus, which uses
an origin of replication to remain in latency in human cells [14–
16]. Thus we investigated whether the circular genomic elements
were plasmids or viruses by screening the apparently circular
contigs for plasmid-specific motifs, including the origin of
replication, using PlasMapper [13]. We found no evidence for
these signals. The method for identification of circular genomes
described here permitted us to characterize 9.3% of the unknown
sequences including the putative novel papillomavirus identified in
this study. Additional studies are needed to fully characterize these
putative novel viral genomic structures.
All contigs were further analyzed with tBLASTx against NCBI
sequences to assign taxonomy. This analysis revealed that a contig
constructed with 599 sequencing reads had a significant similarity
to HPV sequences. The contig was named HPV_SD2.
Genomic Organization of and Phylogenetic Analysis of
HPV_SD2
The complete genome of HPV_SD2 (Figure 3) is 7,299 bp long
with a GC content of 36.3%. The genomic organization of
HPV_SD2 includes 7 open reading frames (L2, L1, E6, E7, E1, E2
and E4) characteristic of other previously described HPVs. In
addition, there was a 530 bp non-coding long control region
(LCR), also known as an upstream regulatory region (URR)
located between the L1 and E6 genes, at position 3,244 through
3,773 of the genome (Figure 3B). This LCR contains a TATA box
(TATAAA, nucleotide positions 3,735–3,740), a polyadenylated
site (AATAAA, nucleotide positions 3,336–3,341), 3 palindrome
sites (ACCG-N4-CGGT; nucleotide positions 3,483–3,494; 3,650–
3,661 and 3,720–3,731) and 1 degenerate palindrome (ACC-N6-
GGT, positions 3,524–3,535). The palindrome motif ACCG-N4-
CGGT is known to play a crucial role in binding of the E2 protein
[17,18], which mediates viral transcription in trans [19]. The E6
protein contained 2 zinc-binding domains (CxxC-N29-CxxC) at
positions 3,853–3,964 and 4,072–4,182.
The E7 protein is considered as an oncogene of high-risk HPVs
because it shares structural and functional similarities with known
DNA viruses such as SV40 and adenovirus [17,20]. A sequence
coding for a metal-binding domain, including two Cys-X-X-Cys
motifs (CGTC and CSGC) separated by 29 amino acids, was
found within the deduced E7 gene at positions 4,344 through
4,447.
The HPV_SD2 contig from this study were aligned with 155
complete HPV genomes in the PAVE database. The alignment
was carried out using ClustalW 2.1 (default parameters) and all
ambiguities and gaps were removed with GBlocks 0.91 b [21]. We
also included another genome from this study, HPV_SD1,
identified by BLAST analysis. The phylogenetic analysis of both
the complete genome and the L1 gene showed that while
HPV_SD1 was closely related to HPV_49, HPV_SD2 was
a distant relative of gamma papillomaviruses. Indeed, HPV_SD2
clustered strongly with the Gamma-human papillomavirus genus,
with a bootstrap value of 100% (Figure 4). A pair-wise distance
analysis performed with all 155 previously described complete
genome sequences and the L1 gene of papillomavirus showed that
the identity between HPV_SD2 and the closest taxon (HPV128)
was only 61.1% and 63.1%, respectively (Document S3). The
average pair-wise identity between HPV_SD2 and all previously
Discovery of a Novel HPV by Metagenomic Approach
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described complete HPV genomes depicted in Figure 4 was 49.4%
(standard deviation 4.2%, Document S3).
Verification of the Genome Structure of HPV_SD2 by PCR
and Sanger Sequencing
We used PCR as an alternative detection method to determine
if the HPV_SD2 contig generated by 454 sequencing could be
Figure 1. Taxonomical assignment of sequence reads convenient respiratory waste samples. A. Overall proportions of sequences with
homolog in Genbank (the known, 7.8%) compared to sequences with no homolog in Genbank (Unknown, 92.2%). Unknown/Divergent indicates the
proportion of highly divergent and/or novel sequences with no homology to NCBI. B. Proportion of sequences classified as eukaryotes, bacteria and
viruses. Sequences were classified using BLASTn search against all non-redundant nucleotide sequences in the NCBI nt database with an E-value
cutoff of 1025.
doi:10.1371/journal.pone.0058404.g001
Table 1. Summary of known viruses detected in nasopharyngeal samples.
Viral species DNA metagenome RNA metagenome Total Read counts Percentage total read
17,313 12,946 30,259 100%
Human enterovirus C 0 9,926 9,926 36.32
Torque teno virus 8,090 0 8,090 29.61
Torque teno mini virus 3,722 0 3,722 13.62
Human rhinovirus A 0 1,531 1,531 5.60
SEN virus 1,424 0 1,424 5.21
Human rhinovirus C 0 589 589 2.16
Human papillomavirus 571 0 571 2.09
Lactobacillus phage mv4 429 0 429 1.57
Small anellovirus 254 0 254 0.93
Human rhinovirus B 245 0 245 0.90
Human rhinovirus sp. 202 0 202 0.74
Cyclovirus Chimp11 168 0 168 0.61
Human papillomavirus 49 76 0 76 0.28
TTV-like mini virus 67 0 67 0.25
Torque teno mini virus 5 32 0 32 0.12
Streptococcus phage 5093 5 0 5 0.01
BLASTn results. The new HPV-SD2 was not detected by the BLASTn analysis using a cut off E value of 1025.
doi:10.1371/journal.pone.0058404.t001
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found in the sample pool as a double stranded DNA. Three PCR
amplifications (Figure 5A) using primer-pairs 671F-892R, 6838F-
7076R and 6838F-6972R were designed to yield amplicons of 222,
135 and 239 base pairs, respectively. Because the Taq DNA
polymerase was capable to amplify the templates beyond the
primer sites, the primer sets were also expected to generate larger
amplicons containing one or more full genome of HPV_SD2
(7,299 bp) plus a fragment of the size corresponding to the small
amplicon product of the same primer pair (222, 135 and 239 bp).
As depicted in Figure 5B. the PCR reactions with each primer pair
generated the predicted amplicons of the projected sizes. The
presence of these bands indicates that the HPV_SD2 is indeed
a double stranded circular genome.
To confirm the PCR products were HPV_SD2, the large
amplicons containing one full genome shown in Figure 5B were
purified then sequenced using the Sanger method. The resulting
13 sequences were aligned along the original contig generated by
454 sequencing (Figure 6A). The newly generated sequences
covered 4,622 nucleotides including the complete L1 region of
HPV_SD2 (Figure 6B). The total length of these new sequences
represents 63.3% of the HPV_SD2 genome. A pair-wise
comparison between the new sequences and the original contig
(HPV_SD2) showed that the sequences newly generated sequences
were identical to the contig generated with the 454 sequencing,
except for 1 position, which had an insert. Twelve of 13 sequences
were identical to the corresponding region of HPV_SD2 contig
generated by 454 sequencing. Due to the presence of an insertion,
one sequence generated by Sanger method had 99.8% identical
position to HPV_SD2. Close look at this sequence suggested the 1
base insert was due to quality call in Sanger sequencing. Indeed,
Figure 2. Coverage plot of the circular structure of HPV-SD2. A. Screenshot of the assembly of sequences using the De Novo Assembler set for
98% similarity and 45 bp overlap. The coverage plot is shown in green. Overhanging sequences at the 59 and 39 ends are partially assembled. B. Box
at 59 end and box at 39 end are highlighted to show the similarity between unassembled overhang reads at 59 and 39 ends and corresponding ends
of the consensus sequence.
doi:10.1371/journal.pone.0058404.g002
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the additional insert would cause a frame-shift in the open reading
frame of HPV_SD2, suggesting that the sequencing by 454 was
correct. Overall, the confirmatory Sanger sequencing results were
in agreement with our data by 99.9% (Figure 6C.). Therefore, the
PCR amplification and sequencing confirm the discovery of
a novel circular genome of human papillomavirus HPV_SD2.
Figure 3. Genomic organization of the HPV_SD2 virus. Open reading frames (L2, L1, E6, E7, E1, E2, E4) and a 530 bp non-coding long control
region (LCR) are shown. B. Details of the LCR region showing the TATA box (TATAAA, positions 3735–3740), a polyadenylated site (AATAAA, positions
3336–3341), 3 palindrome sites (ACCG-N4-CGGT; positions 3483–3494, 3650–3661, 3720–3731) and 1 degenerate palindrome (ACC-N6-GGT, positions
3524–3535). C. Metal-binding domains in deduced E6 and E7 proteins.
doi:10.1371/journal.pone.0058404.g003
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Conclusion
This study was carried out to develop a standard operating
procedure for virus discovery using a metagenomic approach. To
increase our sampling range, samples were tested in pools. This
limited our ability to trace back any identified virus to an
individual patient. Thus, we cannot link HPV_SD2 or any of the
other viruses detected to clinical symptoms. Nevertheless, the
metagenomic approach has been shown to be a powerful
technique to detect and characterize new viruses that could have
been missed by culture-dependent approaches or by sequence-
dependent detection using probes. The metagenomic procedures
and bioinformatic methods described in this study are suited for
the detection of novel circular genomes of viruses, including
unknown human papillomaviruses.
More HPV types are likely to be discovered as newer
sequencing capabilities and bioinformatics procedures are being
developed. Based on the L1 ORF, different papillomaviruses of the
same genera and species share at least 60% and 90% pairwise
sequence identity, respectively [2]. According to the definition, the
observed low degree of similarity and high genetic distance to
previously described HPVs (E-M.de Villiers personal communi-
cation), we propose that the HPV_SD2 genome described in this
study represents a novel human papillomavirus type of the
Gamma genus.
Materials and Methods
The materials and methods used in this study are outlined in
Figure 7, and are detailed below.
Figure 4. Maximum likelihood tree showing the clustering of HPV_SD2 with previously documented full-length genomes of human
papillomaviruses. The tree was visualized with the Interactive Tree of Life (iTOL) [32]. Bootstrap values with at least 50%, 75% or 100% (100 re-
samplings) are indicated. Note, another HPV_SD1 from this study was added in this analysis clustered with reference HPV_49.
doi:10.1371/journal.pone.0058404.g004
Discovery of a Novel HPV by Metagenomic Approach
PLOS ONE | www.plosone.org 6 March 2013 | Volume 8 | Issue 3 | e58404
Discovery of a Novel HPV by Metagenomic Approach
PLOS ONE | www.plosone.org 7 March 2013 | Volume 8 | Issue 3 | e58404
Ethics Statement
Convenience samples analyzed in this study were originally
collected as part of a febrile respiratory illness study conducted by
the US Naval Health Research Center (NHRC). The study cohort
included military recruits from various training facilities through-
out the United States, residents of the US/Mexico border in and
near San Diego, and military dependents. That study was
approved by the NHRC Institutional review board and a signed
consent was obtained from all patients prior to enrollment.
Samples were transferred to SDSU as part of virus discovery
collaboration between NHRC, Global Viral Forecasting, Inc. and
SDSU, and included patients with pneumonia, febrile respiratory
illness, and healthy controls. The metagenomic study described
here was approved by SDSU’s Health Service Biological Use
Authorization (BUA 06-02-062R).
Sample Preparation
Samples were collected with nasopharyngeal and oropharyngeal
swabs and stored at 280uC in transport media (Remel Micro-
testTM M4 or Remel MicrotestTM M4RT, Lenexa, KS, USA).
Testing was performed in pools of 10, 35 or 75 samples using
40 ml, 100 ml and 100 ml, respectively (Table 2). Pooled samples
were mixed with an equal volume of sodium magnesium solution
(35.8 g/L, NaCl; 2 g/L, MgSO4 7H2O; 12.5 mM TrisCl, pH 7.4)
and filtered through 0.45 mm filters (Whatman, USA) to remove
eukaryotic cells, bacteria and large debris. The filtrates containing
viral particles, bacteria and cells that could not be removed by
filtration, were treated with chloroform (20% of the total volume)
to lyse any eukaryotic host cells and denature lipid bi-layers of
enveloped viruses and bacteria. Samples were then treated with
DNase I (0.7 units/ml of sample) to remove any free DNA. DNA
and RNA were extracted concurrently using the QIAamp
MinElute virus spin kit (Qiagen, cat. 51104, USA). The extracted
materials containing both DNA and RNA was treated with
RNase-free DNase I, then the RNA was reverse transcribed to
cDNA using the Retroscript kit (Ambion, USA) (Libraries:
LIB3RNA, LIB8RNA and LIB10RNA). Alternatively, the extrac-
tion of RNA for 2 libraries (LIB24RNA and LIB25RNA) was
carried out using the Trizol-LS method according to manufacturer
instructions, followed by cDNA synthesis using the TransPlex
Complete Whole Transcriptome Amplification Kit (Sigma-Al-
drich, Cat. WTA2, St. Louis, MO, USA). Four aliquots of each
DNA and cDNA library were amplified by a phi29 DNA
polymerase full-genome amplification method [22] then pooled
together to minimize preferential amplification of small circular
viruses. Amplified DNA and cDNA were then purified using the
NucleoSpinH Tissue Kit (Clontech, Mountain View, CA 94043,
USA). Epifluorescence microscopy was used to ascertain the
presence of microbes and viruses before and after chloroform
treatment [23].
Sequencing was carried out using the Roche 454 FLX titanium
according to the manufacturer’s protocol (454 Life Sciences
Corporation, Roche, Brandford, CT, USA). Approximately 0.5–
5 mg of purified DNA was fragmented by applying a 30 psi
nitrogen pressure for 1 minute. Fragmentation was not required
for the cDNA amplicons, as their sizes were within the required
range for optimal pyrosequencing (150–800 bp). The fragmented
DNA and cDNA ligated to 2 different oligo adaptors, each specific
to 39 or 59 ends. The DNA/cDNA-adaptor complexes were
attached to beads, which were encapsulated into individual micro-
reactor micelles in which the fragments were amplified by
emulsion PCR (emPCR) [24]. The clonally amplified DNA and
cDNA were then loaded into a picotiter plate device in the 454
FLX sequencer to generate DNA sequences [24].
Bioinformatics and Taxonomic Classification
Prior to data analysis, all metagenomic data was pre-processed
through a pipeline of software including, TagCleaner, PRINSEQ
and DeconSeq [25,26]. TagCleaner was used to remove primers
added during cDNA synthesis with WTA Kit [27]. PrinSeq was
used to remove low-quality sequences and artifacts. Human DNA
was filtered out of each metagenome using the DeconSeq software.
Sequence reads in each metagenome were analyzed either
unassembled or as assembled contigs to determine the viral and
microbial relative abundance and diversity of each sample pool.
The taxonomic assignment of each sequence or assembled contig
was carried out using BLASTn (version 2.2.18) by comparing
metagenomic sequences with the GenBank non-redundant nucle-
otide database [28] using a threshold E-value of #1025. In the
case where several related taxa yielded an equally high scoring top
hit, reads were assigned to most recent common ancestor. Scores
for these ancestral clades were calculated as the sum of the scores
in all daughter clades [29]. Sequences with no homology in
Genbank are referred to as unknowns.
Linearity and Circularity Analysis
Sequences from each metagenome with no significant hit to
Genbank were assembled using the GS De Novo Assembler (454
Life Sciences Corporation, Roche, Banford, CT, USA) with
requirements set at 95% identity and at least 45 bp overlaps. The
assembled sequence reads and their related contigs were aligned
using Geneious version 5.4 [30]. A Perl script (Document S2:
circular_from_ACE.pl) was developed to determine the linearity
or circularity of the unknown contigs. The analysis was performed
on the ACE files generated by the De Novo Assembler.
Screening for Plasmid-specific Features
The PlasMapper [13], a web server interface that automatically
generates and annotates circular plasmid maps, was used to
determine if circular genomes found in this study had plasmid-
specific patterns including promoters, terminators and replication
origins. In addition to plasmid-specific features, PlasMapper [13]
and Genious Pro 5.4.3 [30] were used to identify open reading
frames in circular contigs.
Human Papillomavirus Phylogeny
Taxonomical classification was performed initially with
BLASTn and tBLASTx, and contigs with significant hits to
Figure 5. Confirmatory PCRs to verify HPV_SD2 is a circular double-stranded genome. A. Graphical representation of the binding sites of
primers 671F-892R on the putative circular structure of HPV_SD2, and the predicted PCR product sizes (I: 222 bp, II: 7,591 bp, III: 14,890 bp). The
predicted short band (I) indicates the amplification of the proximal region between primers 671F and 892R. The large band (II) indicates that Taq DNA
polymerase would amplify the region between the primers 671F and 892R by making the full circle of the HPV genome. The large band (III) indicates
the Taq DNA polymerase would make 2 full circle around the HPV genome. PCRs were also performed using primer sets 6838F-6972R, 6838F-7076R.
B. Agarose gel (0.5%) showing the amplified HPV_SD2. Primer sets used are shown: primer sets 6838F-6972R, 6838F-7076R. For each PCR, the same
sample pool was tested at different concentrations [1:1 (lanes 1, 4, 7), 1:10 (lanes 2, 5, 8) and 1:50 (lanes (3, 6, 9)] using 1 ml per reaction. L: DNA ladder.
Amplicons can be seen at the expected sizes.
doi:10.1371/journal.pone.0058404.g005
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Figure 6. Confirmatory sequencing of full-genome amplicons generated by PCR. A. For each amplicons, the sequencing was carried out
with primers other than those used for full-genome amplification. The linear sequencing template (black line), the PCR primers are shown at both
ends of the amplicons. Bleu lines (amplicons 671F-892R), green lines (amplicons 6838F-6972R), red lines (amplicons 6838F-7076R) represent the
sequenced regions attached to the corresponding sequencing primers. Numbers included in primer IDs represent the position relative to HPV_SD2
genome. B. Alignment of sequences generated by Sanger method along the HPV_SD2 generated by 454 sequencing. Bars in blue, green and red
correspond to sequences shown in Figure 6A. The newly generated sequences covered 4,622 nucleotides representing 63.3% of the total HPV_SD2
genome. C. Comparison of the sequences generated by Sanger method and HPV_SD2 contig generated by 454 sequencing. Size of each Sanger
sequence and percentage identity are shown.
doi:10.1371/journal.pone.0058404.g006
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human papillomavirus were aligned with complete genomes of
human papilloma virus (HPV) reference sequences obtained from
the Papillomavirus Episteme (PAVE) database. HPV_SD1 and
HPV_SD2 from this study were aligned with PAVE sequences
using ClustalW 2.1 (default parameters) and all ambiguities and
gaps were removed with GBlocks 0.91 b [21]. A phylogenetic tree
was constructed using PhyML 3.0.1 [31] with the following
parameters: NNI tree topology search, HKY85 model of
nucleotide substitution, discrete gamma model with 4 categories,
estimated proportion of invariant sites and transition/transversion
ratio. Bootstrap analysis using 100 resampling iterations was
performed to validate the phylogenetic assignment of previously
described HPV full-length genomes and to provide quality
assurance of the classification of sequences. The tree was visualized
with the Interactive Tree of Life (iTOL) [32].
Confirmation by Complete Genome Amplification and
Sanger Sequencing
Three polymerase chain reaction assays were performed to
verify if the sequence reads assembled by the metagenomic
approach derived from a complete circular double-stranded DNA
in the swab sample. We designed 5 PCR primers 671F: 59-ACCA
GGCC CAAC TCCC CCAA A-39; 892R: 59-GACG GTCC
Figure 7. Outline of methods.
doi:10.1371/journal.pone.0058404.g007
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CGCC TTTT CTTG A-39; 7076R: 59-CCGT TTGG CACT
GGGG GAGG-39; 6838F: 59-CCGC CTGC GACT CCGA
AGAA-39 and 6972R: 59-GCGG CGAT GCGG TGGT AGTT-
39, each identical to HPV_SD2 at positions 671–691, 872–892,
7057–7076, 6838–6857, 6953–7072. Three PCR reactions were
designed to amplify the HPV_SD2 using primer sets 671F-892R,
6838F-7076R and 6838F-6972R (Figure 5A). The PCR amplifi-
cation was performed using the Thermo Scientific Extensor Hi-
Fidelity PCR Master Mix following manufacturer instruction
(Thermo Fisher Scientific, Inc.). Given the large size of the
amplicons and different melting temperatures of primers, we
employed a touchdown approach that allowed us to amplify all the
PCR products using the same conditions. The cycling conditions
were as follows: 1) Denaturation, 94uC for 2 minutes; 2)
denaturation, 94uC for 10 seconds; 3) Annealing, 58uC for 30
seconds; Touch-down, 20.5uC per cycle; 4) Elongation, 68uC for
8 minutes; 5) Repeat steps 2–4 28 times; 6) Elongation, 68uC for 7
minutes; store sample at 4uC until use. A 10 ml aliquot of the PCR
reaction was run in a 0.5% agarose gel and any amplified
amplicon was viewed by ultra violet trans-luminescence. The sizes
of the predicted amplicon for these primer sets were 222, 135 and
239 bp, respectively. Assuming that HPV_SD2 is circular (see
Figure 5A), each primer set (671F-892R, 6838F-7076R and
6838F-6972R) would also generate at least one larger fragment
representing one or more complete genome of HPV_SD2
(7,299 bp) plus the corresponding small amplicon (222, 135, 239
base pairs, respectively) generated by the same primer set.
The resulting full-genome linear PCR amplicons were excised
from the agarose gels and then purified using ZymocleanTM Gel
DNA Recovery kit according to the manufacturer’s instructions.
Purified amplicons were shipped on dry ice to Eton Bioscience
(5820 Oberlin Drive, Suite 100; San Diego, CA 92121) for
sequencing. The sequencing was carried out using the Sanger
method with primers other than those used for the full-genome
amplification (Figure 5).
Sequence Data
The HPV_SD2 was linearized inside the E2 gene at nucleotide
1087 of this gene (i.e. 140 nt before the end of the E2 gene) and
deposited to Genbank under the accession id: KC113191. The
raw metagenomic pyrosequencing reads were submitted to
Sequencing Read Archive (SRA) database under the accession
id: SRA051429.
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